Cecil, Denise L.
Curtis, Benjamin
Gad, Ekram
Gormley, Michael
Timms, Andrew E.
Corulli, Lauren
Bos, Rinke
Damle, Rajendra N.
Sepulveda, Manuel A.
Disis, Mary L.
Funding for this research was provided by:
Janssen Pharmaceuticals
Athena Professorship for Breast Cancer Research
American Cancer Society
Article History
Received: 3 January 2022
Accepted: 3 August 2022
First Online: 10 August 2022
Competing interests
: M.L.D. is a stockholder in EpiThany and receives grant support from Celgene, EMD Serono, Pfizer, Janssen, and Precigen. M.G., R.B., R.N.D. and M.A.S. are stockholders in Janssen. D.L.C. and M.L.D. are inventors on patents held by the University of Washington. No conflicts are declared for B.C., E.G., A.E.T. or L.C.